search
Back to results

Effects of Amino Acids on Regional Lipid Metabolism

Primary Purpose

Hypertriglyceridemia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Amino acids
Placebo
Sponsored by
University of Arkansas
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Hypertriglyceridemia focused on measuring aging, lipid metabolism, very low density lipoproteins, amino acids, dietary supplements

Eligibility Criteria

50 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 50-75 years.
  • Men and Women (Women postmenopausal).
  • Ability to sign informed consent, including ≥26 Mini-Mental State Exam.
  • Plasma triglyceride concentration between 130-500 mg/dl.

Exclusion Criteria:

  • Diabetes (plasma glucose: fasting ≥126 mg/dl or ≥200 mg/dl at 2 hr after 75 g glucose load).
  • On diabetes medication or lipid altering agents, including over the counter fish oil/omega 3 fatty acids.
  • Kidney/renal or liver disease.
  • Bleeding disorders or anemia.
  • Endocrine disease.
  • Positive hepatitis or HIV screens.
  • Alcohol abuse or drug abuse
  • Score of <26 on the Mini-Mental State Exam.
  • Allergy to iodine or fish products.
  • Subjects with cerebral aneurysm clips, internal transistorized devices (e.g., neural stimulators), or cardiac pacemakers.

Sites / Locations

  • University of Arkansas for Medical Science, Reynolds Aging Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Amino acids

Placebo

Arm Description

Amino acid supplementation between meals for eight weeks

Supplementation of placebo (inert components) between meals for eight weeks

Outcomes

Primary Outcome Measures

Very low density lipoprotein (VLDL) turnover
Turnover rates of VLDL-triglycerides and VLDL-ApoB-100, including synthesis and breakdown rates, measured before and after eight weeks of amino acid supplementation

Secondary Outcome Measures

Fat oxidation
Fat oxidation measured before and after eight weeks of amino acid supplementation
Lipolysis
Lipolysis measured before and after eight weeks of amino acid supplementation
Triglyceride uptake in muscle and adipose tissue
Triglyceride uptake in muscle and adipose tissue measured before and after eight weeks of amino acid supplementation

Full Information

First Posted
June 22, 2010
Last Updated
October 25, 2016
Sponsor
University of Arkansas
Collaborators
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT01150188
Brief Title
Effects of Amino Acids on Regional Lipid Metabolism
Official Title
Effects of Amino Acids on Regional Lipid Metabolism
Study Type
Interventional

2. Study Status

Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
June 2010 (undefined)
Primary Completion Date
August 2016 (Actual)
Study Completion Date
August 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Arkansas
Collaborators
National Institute on Aging (NIA)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Elevated fat level in blood is a risk factor for coronary heart disease, a major cause of death in America. The overall goal of this project is to test a novel treatment using nutrient (amino acid) supplementation against this condition in men and women, and to understand how this treatment works.
Detailed Description
Coronary heart disease (CHD) remains the single largest killer of American men and women (45). Hyper¬triglyceridemia (elevated triglyceride [TG] concentration in the blood) has been shown to be a significant independent risk factor for CHD (7;8;25), accordingly, treatment for hypertriglyceridemia has been included in the Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program (36). In a meta-analysis of 21 population-based prospective studies including a total of 65,863 men and 11,089 women, each increase of 89 mg/dl (1 mmol/l) in TG concentration was associated with a 32% increase in CHD risk in men and 76% increase in women (3). Thus, hypertriglyceridemia is an even stronger risk factor for CHD in women than in men. The prevalence of hypertriglyceridemia is high. It is a common finding with aging, and is also associated with overweight, obesity, diabetes, and renal disease (39). With the aging of the US population and ongoing epidemics of obesity and type 2-diabetes, the number of individuals with conditions associated with elevated TG levels is likely to grow. 4.1.2 Effect of Amino Acids on Plasma Triglyceride Concentration In an effort to clarify the potential independent effect of protein on plasma and tissue lipids, we supplemented a normal weight-maintaining diet with a relatively small amount of amino acids (~90 kcal/day) between meals. We measured tissue lipids in addition to plasma lipids since the increase in insulin resistance with aging has been linked to increased fat accumulation in muscle and liver tissue (20;63). Also, it has repeatedly been shown that amino acid intake stimulates muscle protein synthesis and improves muscle protein net balance (86). Our hypothesis was that supplementation of the normal diet with a mixture of amino acids will reduce circulating and tissue TG concentrations and improve insulin sensitivity in elderly subjects with impaired glucose tolerance. Twelve impaired glucose tolerant elderly ingested 11 g of essential amino acids (EAA) + arginine twice a day for 16 weeks, after a 7 week control run in. Diet and activity were not otherwise modified. We found individuals consuming the EAA supplement had improved physical function. Further, these individuals had lower plasma and liver TG concentrations than before supplementation, and total cholesterol and VLDL-cholesterol concentrations were also lower after supplementations (12). In the present study, we will investigate this by supplementing the diet of older subjects shown to have hypertriglyceridemia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertriglyceridemia
Keywords
aging, lipid metabolism, very low density lipoproteins, amino acids, dietary supplements

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
125 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Amino acids
Arm Type
Active Comparator
Arm Description
Amino acid supplementation between meals for eight weeks
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Supplementation of placebo (inert components) between meals for eight weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
Amino acids
Intervention Description
11 g amino acids two times per day for eight weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Placebo of inert compounds, 11 g two times per day for eight weeks
Primary Outcome Measure Information:
Title
Very low density lipoprotein (VLDL) turnover
Description
Turnover rates of VLDL-triglycerides and VLDL-ApoB-100, including synthesis and breakdown rates, measured before and after eight weeks of amino acid supplementation
Time Frame
Eight weeks
Secondary Outcome Measure Information:
Title
Fat oxidation
Description
Fat oxidation measured before and after eight weeks of amino acid supplementation
Time Frame
8 weeks
Title
Lipolysis
Description
Lipolysis measured before and after eight weeks of amino acid supplementation
Time Frame
8 weeks
Title
Triglyceride uptake in muscle and adipose tissue
Description
Triglyceride uptake in muscle and adipose tissue measured before and after eight weeks of amino acid supplementation
Time Frame
Eight weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 50-75 years. Men and Women (Women postmenopausal). Ability to sign informed consent, including ≥26 Mini-Mental State Exam. Plasma triglyceride concentration between 130-500 mg/dl. Exclusion Criteria: Diabetes (plasma glucose: fasting ≥126 mg/dl or ≥200 mg/dl at 2 hr after 75 g glucose load). On diabetes medication or lipid altering agents, including over the counter fish oil/omega 3 fatty acids. Kidney/renal or liver disease. Bleeding disorders or anemia. Endocrine disease. Positive hepatitis or HIV screens. Alcohol abuse or drug abuse Score of <26 on the Mini-Mental State Exam. Allergy to iodine or fish products. Subjects with cerebral aneurysm clips, internal transistorized devices (e.g., neural stimulators), or cardiac pacemakers.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elisabet Borsheim, PhD
Organizational Affiliation
University of Arkansas
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Arkansas for Medical Science, Reynolds Aging Institute
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72205
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Effects of Amino Acids on Regional Lipid Metabolism

We'll reach out to this number within 24 hrs